Better Buy: AbbVie vs. Johnson & Johnson

In this battle of relatively new vs. well established drugmakers, which is the better choice for long-term investors?

Investors have made a lot of money from Big Pharma stocks over the past few years. Two of the biggest winners have quite different backgrounds. AbbVie (NYSE:ABBV) is a spin-off less than four years old. Johnson & Johnson (NYSE:JNJ) has been around since Grover Cleveland was president. But that's the past. Which of these two stocks has the brighter future? 

Here are arguments for both AbbVie and J&J... 


Source: The Motley Fool